Veeva Systems Inc. has announced that Merck, also known as MSD outside the United States and Canada, has committed to using Veeva Vault CRM. This strategic move is set to support Merck as it embarks on one of its most significant launch periods, spanning various new therapeutic areas and modalities. Dave Williams, Merck's executive vice president and chief information and digital officer, expressed excitement about expanding the partnership with Veeva, highlighting the shared commitment to customer success. Veeva CEO Peter Gassner praised Merck's leadership in science and expressed honor in extending their partnership to include Vault CRM. The Vault CRM solution, part of the Vault CRM Suite, offers advanced global capabilities tailored to meet unique regional and compliance requirements, enhancing commercial execution across both personal and digital channels.